INTERNATIONAL PATENT: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD., 正大天晴药业集团股份有限公司 FILES APPLICATION FOR "COMBINATION OF SIRNA AGENT AND REVERSE TRANSCRIPTASE INHIBITOR AND USE THEREOF IN TREATING HEPATITIS B"

GENEVA, Nov. 30 -- CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (No. 369 Yuzhou South Rd.，Lianyungang, Jiangsu 222062), 正大天晴药业集团股份有限公司 (中国江苏省连云港市郁州南路369号) filed a patent application (PCT/CN2025/096544) for "COMBINATION OF SIRNA AGENT AND REVERSE TRANSCRIPTASE INHIBITOR AND USE THEREOF IN TREATING HEPATITIS B" on May 22, 2025. With publication no. WO/2025/242164, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) sy...